Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Innovation Pharmaceuticals Inc.
Headquarters: Beverly, MA, United States of America
Website: http://www.ipharminc.com
Year Founded: 2007
Status: Public
Industry Sector: HealthTechnology
CEO: Leo Ehrlich, CPA
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: -0.02
Exchange/Ticker 1: Pink:IPIX
Exchange/Ticker 2: N/A
Latest Market Cap: $104,100
BioCentury | Sep 9, 2022
Management Tracks
Misciattelli becomes CEO of Aavantgarde
Plus new CMO, SVP of clinical development at Alumis, and updates from Vertex, Third Rock, AiCuris and more
BioCentury | Jan 12, 2018
Clinical News
Innovation's Brilacidin-OM meets in Phase II for oral mucocitis
BioCentury | May 24, 2017
Clinical News
Cellceutix completes enrollment in Phase II for ulcerative proctitis
Items per page:
1 - 5 of 5